👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Britain becomes first nation to legalise three-parent babies

Published 24/02/2015, 21:45
© Reuters.  Britain becomes first nation to legalise three-parent babies

By Kate Kelland, Health, and, Science and Correspondent

LONDON (Reuters) - Britain will become the first nation to legalise a "three-parent" IVF technique which doctors say can prevent some inherited incurable diseases but which critics fear will effectively lead to "designer babies".

After more than three hours of debate, lawmakers in parliament's upper house voted on Tuesday for a change in the law to allow the treatments, echoing a positive vote in the lower house earlier this month.

The treatment, called mitochondrial transfer, is known as "three-parent" in vitro fertilisation (IVF) because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a female donor.

Although the techniques are still at the research stage in laboratories in Britain and the United States, experts say that now legal hurdles have been overcome, Britain's first 3-parent baby could be born as early as 2016.

Mitochondrial transfer involves intervening in the fertilisation process to remove faulty mitochondrial DNA, which can cause inherited conditions such as heart problems, liver failure, brain disorders, blindness and muscular dystrophy.

Mitochondria act as tiny energy-generating batteries inside cells, and around 1 in 6,000 babies around the world are born with serious mitochondrial disorders.

Responding to the vote, Jeremy Farrar, director of the Wellcome Trust medical charity commended lawmakers for a "considered and compassionate decision".

"Families who know what it is like to care for a child with a devastating disease are the people best placed to decide whether mitochondrial donation is the right option," he said.

Mark Downs, chief executive of the Society of Biology, hailed "a great day for UK science" and said the landmark decision "will ensure mothers who carry faulty mitochondria can have healthy children free from the devastating conditions."

But Marcy Darnovsky, director of the campaign group The Centre for Genetics and Society, called the move a "historic mistake" which turns children into biological experiments and will "forever alter the human germline".

"The techniques ... are relatively crude and will not in and of themselves create so-called designer babies," she said.

"However, they will result in children with DNA from three different people in every cell of their bodies, which will impact a large range of traits in unknowable ways and introduce genetic changes that will be passed down to future generations."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.